Store | JAMA Product Details

< Continue Shopping

JAMA

Visit the Site

Single Article Purchase:
FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products
Bridget M. Kuehn
JAMA. 2009;301(22):2316-2316.
Published online June 10, 2009

Select Pricing Criteria:

Location:

Subscriber:

Subscription:

Choose criteria for pricing info

Want online access for an institution? Learn More/Request Quote >

Cart:0 Items

View / Checkout

Username:

Password:

Forgot your password?

If you have not completed an online registration click here

Close

Forgot Your Password?

Enter your username and email address. We'll send you a link to reset your password.

Username:*

(required)

Email:*

(required)

Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.

Need assistance?

Contact Customer Support

For Institutions

Learn More about access options for institutions, including site licenses, print only subscriptions, and access to the Backfiles.

JAMA

For Institutions

The JAMA Network

Content

Services

The JAMA Network

Sites

AMA Publishing Group Journals

Information For

Services

Content Resources

Other Resources